N-Nitroso Edoxaban Impurity 4
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs .N-Nitroso Edoxaban Impurity 4 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 4 chemically represented as 2-bromo-5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridine . Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 4 .We supply N-Nitroso Edoxaban Impurity 4 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-E5017 |
| CAS No | 720720-96-7 |
| Mol.F. | C8H10N2O2S : HCl |
| Mol.Wt. | 198.2 : 36.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E5018 |
| CAS No | 1072-98-6 |
| Mol.F. | C5H5ClN2 |
| Mol.Wt. | 128.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E5019 |
| CAS No | 480452-37-7 |
| Mol.F. | C16H22ClN5O3 |
| Mol.Wt. | 367.83 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-E5020 |
| CAS No | 2803419-53-4 |
| Mol.F. | C25H35N7O3S2 |
| Mol.Wt. | 545.72 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-E5021 |
| CAS No | 480450-85-9 |
| Mol.F. | C21H31N5O5S |
| Mol.Wt. | 465.56 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-E5022 |
| CAS No | 1093351-29-1 |
| Mol.F. | C24H29ClN6O5S |
| Mol.Wt. | 549.04 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-E5023 |
| CAS No | 2244103-96-4 |
| Mol.F. | C24H30ClN7O5S |
| Mol.Wt. | 564.1 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-E5024 |
| CAS No | NA |
| Mol.F. | C25H33ClN7O4S : I |
| Mol.Wt. | 563.1 : 126.9 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-E5025 |
| CAS No | NA |
| Mol.F. | C23H27ClN6O5S |
| Mol.Wt. | 535.0 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-E5026 |
| CAS No | 775280-48-3 |
| Mol.F. | C24H30BrN7O4S |
| Mol.Wt. | 592.5 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-E5027 |
| CAS No | 1807315-98-5 |
| Mol.F. | C16H22ClN5O3 : CH4O3S |
| Mol.Wt. | 367.8 : 96.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E5028 |
| CAS No | NA |
| Mol.F. | C38H45Cl2N11O7S |
| Mol.Wt. | 870.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E5029 |
| CAS No | 740794-83-6 |
| Mol.F. | C23H28ClN7O4S |
| Mol.Wt. | 534.0 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-E5031 |
| CAS No | NA |
| Mol.F. | C21H30ClN5O5 |
| Mol.Wt. | 468.0 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E5032 |
| CAS No | 2067228-51-5 |
| Mol.F. | C12H21NO5 |
| Mol.Wt. | 259.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014040 |
| CAS No | NA |
| Mol.F. | C6H8N4OS |
| Mol.Wt. | 184.22g/mol |
| INV STATUS | In Stock |